RGS-Insensitive Gα Subunits: Probes of Gα Subtype-Selective Signaling and Physiological Functions of RGS Proteins

Methods in Molecular Biology

Volumn 756, Issue , 2011, Pages 75-98

  Kaur, Kuljeet ^a   Kehrl, Jason M ^a   Charbeneau, Raelene A ^a   Neubig, Richard R ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

G protein coupled receptor; GTPase activating protein; Heterotrimeric G protein; Regulator of G protein signaling protein; Signal transduction

Indexed keywords

G PROTEIN COUPLED RECEPTOR; RGS PROTEIN;

ANIMAL; ARTICLE; GENE TARGETING; GENETICS; HUMAN; METABOLISM; METHODOLOGY; MUTATION; PROTEIN SUBUNIT; SIGNAL TRANSDUCTION;

ANIMALS; GENE TARGETING; HUMANS; MUTATION; PROTEIN SUBUNITS; RECEPTORS, G-PROTEIN-COUPLED; RGS PROTEINS; SIGNAL TRANSDUCTION;

MUS; RODENTIA;

EID: 80054772565     PISSN: 10643745     EISSN: 19406029     Source Type: Book Series    
DOI: 10.1007/978-1-61779-160-4_4     Document Type: Chapter

References (77)

1. Sternweis, P. C., Northup, J. K., Smigel, M. D., and Gilman, A. G. (1981) The regulatory component of adenylate cyclase. Purification and properties. J Biol Chem 256, 11517–26.
2. Ross, E. M., and Gilman, A. G. (1980) Biochemical properties of hormone-sensitive adenylate cyclase. Annu Rev Biochem 49, 533–64.
3. Chabre, M., and Deterre, P. (1989) Molecular mechanism of visual transduction. Eur J Biochem 179, 255–66.
4. Arshavsky, V., and Bownds, M. D. (1992) Regulation of deactivation of photoreceptor G protein by its target enzyme and cGMP. Nature 357, 416–7.
5. Dratz, E. A., Lewis, J. W., Schaechter, L. E., Parker, K. R., and Kliger, D. S. (1987) Retinal rod GTPase turnover rate increases with concentration: a key to the control of visual excitation? Biochem Biophys Res Commun 146, 379–86.
6. Adari, H., Lowy, D. R., Willumsen, B. M., Der, C. J., and McCormick, F. (1988) Guanosine triphosphatase activating protein (GAP) interacts with the p21 ras effector binding domain. Science 240, 518–21.
7. Dohlman, H. G. (2002) G proteins and pheromone signaling. Annu Rev Physiol 64, 129–52.
8. Chan, R. K., and Otte, C. A. (1982) Isolation and genetic analysis of Saccharomyces cerevisiae mutants supersensitive to G1 arrest by a factor and alpha factor pheromones. Mol Cell Biol 2, 11–20.
9. Dietzel, C., and Kurjan, J. (1987) Pheromonal regulation and sequence of the Saccharomyces cerevisiae SST2 gene: a model for desensitization to pheromone. Mol Cell Biol 7, 4169–77.
10. Dohlman, H. G., Apaniesk, D., Chen, Y., Song, J., and Nusskern, D. (1995) Inhibition of G-protein signaling by dominant gain-of-function mutations in Sst2p, a pheromone desensitization factor in Saccharomyces cerevisiae. Mol Cell Biol 15, 3635–43.
11. Koelle, M. R., and Horvitz, H. R. (1996) EGL-10 regulates G protein signaling in the C. elegans nervous system and shares a conserved domain with many mammalian proteins. Cell 84, 115–25.
12. Druey, K. M., Blumer, K. J., Kang, V. H., and Kehrl, J. H. (1996) Inhibition of G-protein-mediated MAP kinase activation by a new mammalian gene family. Nature 379, 742–6.
13. Berman, D. M., Wilkie, T. M., and Gilman, A. G. (1996) GAIP and RGS4 are GTPase-activating proteins for the Gi subfamily of G protein alpha subunits. Cell 86, 445–52.
14. Dohlman, H. G., and Thorner, J. (1997) RGS proteins and signaling by heterotrimeric G proteins. J Biol Chem 272, 3871–4.
15. Hollinger, S., and Hepler, J. R. (2002) Cellular regulation of RGS proteins: modulators and integrators of G protein signaling. Pharmacol Rev 54, 527–59.
16. Ross, E. M., and Wilkie, T. M. (2000) GTPase-activating proteins for heterotrimeric G proteins: regulators of G protein signaling (RGS) and RGS-like proteins. Annu Rev Biochem 69, 795–827.
17. Neubig, R. R., and Siderovski, D. P. (2002) Regulators of G-protein signalling as new central nervous system drug targets. Nat Rev Drug Discov 1, 187–97.
18. Zhong, H., and Neubig, R. R. (2001) Regulator of G protein signaling proteins: novel multifunctional drug targets. J Pharmacol Exp Ther 297, 837–45.
19. Traynor, J. R., and Neubig, R. R. (2005) Regulators of G protein signaling & drugs of abuse. Mol Interv 5, 30–41.
20. Gold, S. J., Ni, Y. G., Dohlman, H. G., and Nestler, E. J. (1997) Regulators of G-protein signaling (RGS) proteins: region-specific expression of nine subtypes in rat brain. J Neurosci 17, 8024–37.
21. Doupnik, C. A., Xu, T., and Shinaman, J. M. (2001) Profile of RGS expression in single rat atrial myocytes. Biochim Biophys Acta 1522, 97–107.
22. Grafstein-Dunn, E., Young, K. H., Cockett, M. I., and Khawaja, X. Z. (2001) Regional distribution of regulators of G-protein signaling (RGS) 1, 2, 13, 14, 16, and GAIP messenger ribonucleic acids by in situ hybridization in rat brain. Brain Res Mol Brain Res 88, 113–23.
23. Liu, W., Yuen, E. Y., Allen, P. B., Feng, J., Greengard, P., and Yan, Z. (2006) Adrenergic modulation of NMDA receptors in prefrontal cortex is differentially regulated by RGS proteins and spinophilin. Proc Natl Acad Sci U S A 103, 18338–43.
24. Anderson, G. R., Lujan, R., Semenov, A., Pravetoni, M., Posokhova, E. N., Song, J. H., Uversky, V., Chen, C. K., Wickman, K., and Martemyanov, K. A. (2007) Expression and localization of RGS9-2/G 5/R7BP complex in vivo is set by dynamic control of its constitutive degradation by cellular cysteine proteases. J Neurosci 27, 14117–27.
25. Drenan, R. M., Doupnik, C. A., Jayaraman, M., Buchwalter, A. L., Kaltenbronn, K. M., Huettner, J. E., Linder, M. E., and Blumer, K. J. (2006) R7BP augments the function of RGS7*Gbeta5 complexes by a plasma membrane-targeting mechanism. J Biol Chem 281, 28222–31.
26. De Vries, L., Lou, X., Zhao, G., Zheng, B., and Farquhar, M. G. (1998) GIPC, a PDZ domain containing protein, interacts specifically with the C terminus of RGS-GAIP. Proc Natl Acad Sci U S A 95, 12340–5.
27. Murphy, J. J., and Norton, J. D. (1990) Cell-type-specific early response gene expression during plasmacytoid differentiation of human B lymphocytic leukemia cells. Biochim Biophys Acta 1049, 261–71.
28. Moratz, C., Hayman, J. R., Gu, H., and Kehrl, J. H. (2004) Abnormal B-cell responses to chemokines, disturbed plasma cell localization, and distorted immune tissue architecture in Rgs1−/− mice. Mol Cell Biol 24, 5767–75.
29. Heximer, S. P., Knutsen, R. H., Sun, X., Kaltenbronn, K. M., Rhee, M. H., Peng, N., Oliveira-dos-Santos, A., Penninger, J. M., Muslin, A. J., Steinberg, T. H., Wyss, J. M., Mecham, R. P., and Blumer, K. J. (2003) Hypertension and prolonged vasoconstrictor signaling in RGS2-deficient mice. J Clin Invest 111, 445–52.
30. Sun, X., Kaltenbronn, K. M., Steinberg, T. H., and Blumer, K. J. (2005) RGS2 is a mediator of nitric oxide action on blood pressure and vasoconstrictor signaling. Mol Pharmacol 67, 631–9.
31. Gross, V., Tank, J., Obst, M., Plehm, R., Blumer, K. J., Diedrich, A., Jordan, J., and Luft, F. C. (2005) Autonomic nervous system and blood pressure regulation in RGS2-deficient mice. Am J Physiol Regul Integr Comp Physiol 288, R1134-42.
32. Tuomi, J. M., Chidiac, P., and Jones, D. L. (2009) Evidence for enhanced M3 muscarinic receptor function and sensitivity to atrial arrhythmia in the RGS2 deficient mouse. Am J Physiol Heart Circ Physiol. 298,H554-61.
33. Takimoto, E., Koitabashi, N., Hsu, S., Ketner, E. A., Zhang, M., Nagayama, T., Bedja, D., Gabrielson, K. L., Blanton, R., Siderovski, D. P., Mendelsohn, M. E., and Kass, D. A. (2009) Regulator of G protein signaling 2 mediates cardiac compensation to pressure overload and antihypertrophic effects of PDE5 inhibition in mice. J Clin Invest 119, 408–20.
34. Bodenstein, J., Sunahara, R. K., and Neubig, R. R. (2007) N-terminal residues control proteasomal degradation of RGS2, RGS4, and RGS5 in human embryonic kidney 293 cells. Mol Pharmacol 71, 1040–50.
35. Gu, S., Tirgari, S., and Heximer, S. P. (2008) The RGS2 gene product from a candidate hypertension allele shows decreased plasma membrane association and inhibition of Gq. Mol Pharmacol 73, 1037–43.
36. Oliveira-Dos-Santos, A. J., Matsumoto, G., Snow, B. E., Bai, D., Houston, F. P., Whishaw, I. Q., Mariathasan, S., Sasaki, T., Wakeham, A., Ohashi, P. S., Roder, J. C., Barnes, C. A., Siderovski, D. P., and Penninger, J. M. (2000) Regulation of T cell activation, anxiety, and male aggression by RGS2. Proc Natl Acad Sci U S A 97, 12272–7.
37. Grillet, N., Pattyn, A., Contet, C., Kieffer, B. L., Goridis, C., and Brunet, J. F. (2005) Generation and characterization of Rgs4 mutant mice. Mol Cell Biol 25, 4221–8.
38. Mirnics, K., Middleton, F. A., Stanwood, G. D., Lewis, D. A., and Levitt, P. (2001) Disease-specific changes in regulator of G-protein signaling 4 (RGS4) expression in schizophrenia. Mol Psychiatry 6, 293–301.
39. Cifelli, C., Rose, R. A., Zhang, H., Voigtlaender-Bolz, J., Bolz, S. S., Backx, P. H., and Heximer, S. P. (2008) RGS4 regulates parasympathetic signaling and heart rate control in the sinoatrial node. Circ Res 103, 527–35.
40. Bondjers, C., Kalen, M., Hellstrom, M., Scheidl, S. J., Abramsson, A., Renner, O., Lindahl, P., Cho, H., Kehrl, J., and Betsholtz, C. (2003) Transcription profiling of platelet-derived growth factor-B-deficient mouse embryos identifies RGS5 as a novel marker for pericytes and vascular smooth muscle cells. Am J Pathol 162, 721–9.
41. Cho, H., Kozasa, T., Bondjers, C., Betsholtz, C., and Kehrl, J. H. (2003) Pericyte-specific expression of Rgs5: implications for PDGF and EDG receptor signaling during vascular maturation. FASEB J 17, 440–2.
42. Nisancioglu, M. H., Mahoney, W. M., Jr., Kimmel, D. D., Schwartz, S. M., Betsholtz, C., and Genove, G. (2008) Generation and characterization of rgs5 mutant mice. Mol Cell Biol 28, 2324–31.
43. Cho, H., Park, C., Hwang, I. Y., Han, S. B., Schimel, D., Despres, D., and Kehrl, J. H. (2008) Rgs5 targeting leads to chronic low blood pressure and a lean body habitus. Mol Cell Biol 28, 2590–7.
44. Hamzah, J., Jugold, M., Kiessling, F., Rigby, P., Manzur, M., Marti, H. H., Rabie, T., Kaden, S., Grone, H. J., Hammerling, G. J., Arnold, B., and Ganss, R. (2008) Vascular normalization in Rgs5-deficient tumours promotes immune destruction. Nature 453, 410–4.
45. Kuwata, H., Nakao, K., Harada, T., Matsuda, I., and Aiba, A. (2008) Generation of RGS8 null mutant mice by Cre/loxP system. Kobe J Med Sci 53, 275–81.
46. Chen, C. K., Burns, M. E., He, W., Wensel, T. G., Baylor, D. A., and Simon, M. I. (2000) Slowed recovery of rod photoresponse in mice lacking the GTPase accelerating protein RGS9-1. Nature 403, 557–60.
47. Rahman, Z., Schwarz, J., Gold, S. J., Zachariou, V., Wein, M. N., Choi, K. H., Kovoor, A., Chen, C. K., DiLeone, R. J., Schwarz, S. C., Selley, D. E., Sim-Selley, L. J., Barrot, M., Luedtke, R. R., Self, D., Neve, R. L., Lester, H. A., Simon, M. I., and Nestler, E. J. (2003) RGS9 modulates dopamine signaling in the basal ganglia. Neuron 38, 941–52.
48. Zachariou, V., Georgescu, D., Sanchez, N., Rahman, Z., DiLeone, R., Berton, O., Neve, R. L., Sim-Selley, L. J., Selley, D. E., Gold, S. J., and Nestler, E. J. (2003) Essential role for RGS9 in opiate action. Proc Natl Acad Sci U S A 100, 13656–61.
49. Yang, S., and Li, Y. P. (2007) RGS10-null mutation impairs osteoclast differentiation resulting from the loss of [Ca2+]i oscillation regulation. Genes Dev 21, 1803–16.
50. Hernandez-Hansen, V., Bard, J. D., Tarleton, C. A., Wilder, J. A., Lowell, C. A., Wilson, B. S., and Oliver, J. M. (2005) Increased expression of genes linked to FcepsilonRI Signaling and to cytokine and chemokine production in Lyn-deficient mast cells. J Immunol 175, 7880–8.
51. Bansal, G., Xie, Z., Rao, S., Nocka, K. H., and Druey, K. M. (2008) Suppression of immuno-globulin E-mediated allergic responses by regulator of G protein signaling 13. Nat Immunol 9, 73–80.
52. Martin-McCaffrey, L., Willard, F. S., Oliveira-dos-Santos, A. J., Natale, D. R., Snow, B. E., Kimple, R. J., Pajak, A., Watson, A. J., Dagnino, L., Penninger, J. M., Siderovski, D. P., and D’Souza, S. J. (2004) RGS14 is a mitotic spindle protein essential from the first division of the mammalian zygote. Dev Cell 7, 763–9.
53. Larminie, C., Murdock, P., Walhin, J. P., Duckworth, M., Blumer, K. J., Scheideler, M. A., and Garnier, M. (2004) Selective expression of regulators of G-protein signaling (RGS) in the human central nervous system. Brain Res Mol Brain Res 122, 24–34.
54. DiBello, P. R., Garrison, T. R., Apanovitch, D. M., Hoffman, G., Shuey, D. J., Mason, K., Cockett, M. I., and Dohlman, H. G. (1998) Selective uncoupling of RGS action by a single point mutation in the G protein alpha-subunit. J Biol Chem 273, 5780–4.
55. Lan, K. L., Sarvazyan, N. A., Taussig, R., Mackenzie, R. G., DiBello, P. R., Dohlman, H. G., and Neubig, R. R. (1998) A point mutation in Galphao and Galphai1 blocks interaction with regulator of G protein signaling proteins. J Biol Chem 273, 12794–7.
56. Tesmer, J. J., Berman, D. M., Gilman, A. G., and Sprang, S. R. (1997) Structure of RGS4 bound to AlF4-activated G(i alpha1): stabilization of the transition state for GTP hydrolysis. Cell 89, 251–61.
57. Tesmer, J. J. Structure and Function of Regulator of G Protein Signaling Homology Domains. In: Fisher R., ed. Molecular Biology of RGS proteins. Amsterdam: Elsevier; 2010:75–113.
58. Fu, Y., Zhong, H., Nanamori, M., Mortensen, R. M., Huang, X., Lan, K., and Neubig, R. R. (2004) RGS-insensitive G-protein mutations to study the role of endogenous RGS proteins. Methods Enzymol 389, 229–43.
59. Clark, M. J., Harrison, C., Zhong, H., Neubig, R. R., and Traynor, J. R. (2003) Endogenous RGS protein action modulates mu-opioid signaling through Galphao. Effects on adenylyl cyclase, extracellular signal-regulated kinases, and intracellular calcium pathways. J Biol Chem 278, 9418–25.
60. Huang, X., Fu, Y., Charbeneau, R. A., Saunders, T. L., Taylor, D. K., Hankenson, K. D., Russell, M. W., D’Alecy, L. G., and Neubig, R. R. (2006) Pleiotropic phenotype of a genomic knock-in of an RGS-insensitive G184S Gnai2 allele. Mol Cell Biol 26, 6870–9.
61. Roman, D. L., Talbot, J. N., Roof, R. A., Sunahara, R. K., Traynor, J. R., and Neubig, R. R. (2007) Identification of small-molecule inhibitors of RGS4 using a high-throughput flow cytometry protein interaction assay. Mol Pharmacol 71, 169–75.
62. Jin, Y., Zhong, H., Omnaas, J. R., Neubig, R. R., and Mosberg, H. I. (2004) Structure-based design, synthesis, and pharmacologic evaluation of peptide RGS4 inhibitors. J Pept Res 63, 141–6.
63. Clark, M. J., Linderman, J. J., and Traynor, J. R. (2008) Endogenous regulators of G protein signaling differentially modulate full and partial mu-opioid agonists at adenylyl cyclase as predicted by a collision coupling model. Mol Pharmacol 73, 1538–48.
64. Jeong, S. W., and Ikeda, S. R. (2000) Endogenous regulator of G-protein signaling proteins modify N-type calcium channel modulation in rat sympathetic neurons. J Neurosci 20, 4489–96.
65. Chen, H., and Lambert, N. A. (2000) Endogenous regulators of G protein signaling proteins regulate presynaptic inhibition at rat hippocampal synapses. Proc Natl Acad Sci U S A 97, 12810–5.
66. Fu, Y., Huang, X., Zhong, H., Mortensen, R. M., D’Alecy, L. G., and Neubig, R. R. (2006) Endogenous RGS proteins and Galpha subtypes differentially control muscarinic and adenosine-mediated chronotropic effects. Circ Res 98, 659–66.
67. Shi, J., Damjanoska, K. J., Zemaitaitis, B., Garcia, F., Carrasco, G., Sullivan, N. R., She, Y., Young, K. H., Battaglia, G., Van De kar, L. D., Howland, D. S., and Muma, N. A. (2006) Alterations in 5-HT2A receptor signaling in male and female transgenic rats over-express-ing either Gq or RGS-insensitive Gq protein. Neuropharmacology 51, 524–35.
68. Heintz, N. (2001) BAC to the future: the use of bac transgenic mice for neuroscience research. Nat Rev Neurosci 2, 861–70.
69. Zuberi, Z., Birnbaumer, L., and Tinker, A. (2008) The role of inhibitory heterotrimeric G proteins in the control of in vivo heart rate dynamics. Am J Physiol Regul Integr Comp Physiol 295, R1822-30.
70. Goldenstein, B. L., Nelson, B. W., Xu, K., Luger, E. J., Pribula, J. A., Wald, J. M., O’Shea, L. A., Weinshenker, D., Charbeneau, R. A., Huang, X., Neubig, R. R., and Doze, V. A. (2009) Regulator of G protein signaling protein suppression of Galphao protein-mediated alpha2A adrenergic receptor inhibition of mouse hippocampal CA3 epileptiform activity. Mol Pharmacol 75, 1222–30.
71. Talbot, J. N., Jutkiewicz, E. M., Graves, S. M., Clemans, C. F., Nicol, M. R., Mortensen, R. M., Huang, X., Neubig, R. R., and Traynor, J. R. (2010) RGS inhibition at G(alpha)i2 selectively potentiates 5-HT1A-mediated antide- pressant effects. Proc Natl Acad Sci U S A 107, 11086–91
72. Roof, R. A., Jin, Y., Roman, D. L., Sunahara, R. K., Ishii, M., Mosberg, H. I., and Neubig, R. R. (2006) Mechanism of action and structural requirements of constrained peptide inhibitors of RGS proteins. Chem Biol Drug Des 67, 266–74.
73. Willars, G. B. (2006) Mammalian RGS proteins: multifunctional regulators of cellular signalling. Semin Cell Dev Biol 17, 363–76.
74. Nguyen, C. H., Ming, H., Zhao, P., Hugen-dubler, L., Gros, R., Kimball, S. R., and Chidiac, P. (2009) Translational control by RGS2. J Cell Biol 186, 755–65.
75. den Dunnen, J. T., and Antonarakis, S. E. (2001) Nomenclature for the description of human sequence variations. Hum Genet 109, 121–4.
76. Posokhova, E., Wydeven, N., Allen, K. L., Wickman, K., Martemyanov, K. A. (2010) RGS6/Gß5 complex accelerates IKACh gating kinetics in atrial myocytes and modulates parasympathetic regulation of heart rate. Circ Res 107, 1350–4.
77. Yang, J., Huang, J., Maity, B., Gao, Z., Lorca, R. A., Gudmundsson, H., Li, J., Stewart, A., Swaminathan, P. D., Ibeawuchi, S. R., Shepherd, A., Chen, C. K., Kutschke, W., Mohler, P. J., Mohapatra, D. P., Anderson, M. E., Fisher, R. A. (2010) RGS6, a modulator of parasympathetic activation in heart. Circ Res 107, 1345–9.